Related Experiment Video
Updated: Jun 17, 2025

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Comparing glaucoma risk in children receiving low-dose and high-dose glucocorticoid treatment after cataract surgery
Diana Chabané Schmidt1, Torben Martinussen2, Ameenat Lola Solebo3,4
1Department of Ophthalmology, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark.
Insights
Low-dose glucocorticoid treatment after pediatric cataract surgery reduced glaucoma risk in children with longer eyes. High-dose glucocorticoids should be used sparingly in this population to minimize adverse effects.
Area of Science:
- Ophthalmology
- Pediatric Surgery
- Endocrinology
Background:
- Glucocorticoid treatment is vital post-pediatric cataract surgery to manage inflammation.
- However, high-dose glucocorticoids may increase risks of secondary glaucoma and hypothalamic-pituitary-adrenal axis suppression.
Purpose of the Study:
- To compare glaucoma outcomes between high-dose and low-dose postoperative glucocorticoid regimens in children undergoing cataract surgery.
Main Methods:
- A cohort study of Danish children (under 10 years) who had cataract surgery between 2010-2021.
- Compared sustained ocular hypertension or glaucoma (>3 months) between low-dose and high-dose glucocorticoid groups.
- High-dose: subconjunctival depot dexamethasone/methylprednisolone plus topical dexamethasone; Low-dose: topical dexamethasone with a shorter duration and lower frequency.
Main Results:
- 267 children (388 eyes) were analyzed; 95 received high-dose and 173 received low-dose treatment.
- Survival analysis indicated a reduced risk of glaucoma in the low-dose group for children with axial lengths ≥18 mm.
- No significant difference in glaucoma risk was observed for children with shorter eyes.
Conclusions:
- Low-dose glucocorticoid therapy is associated with a lower risk of glaucoma in pediatric cataract surgery patients with axial lengths ≥18 mm.
- High-dose glucocorticoid use should be minimized in pediatric cataract surgery.
- Further research may explore optimal glucocorticoid dosing strategies based on ocular parameters.
Purpose:
Treatment with glucocorticoids following paediatric cataract surgery is crucial to prevent inflammation, but may lead to secondary glaucoma, and hypothalamic-pituitary-adrenal axis suppression. We wish to compare glaucoma outcomes following high-dose and low-dose glucocorticoid treatment after paediatric cataract surgery.
Methods:
This cohort study included Danish children undergoing cataract surgery before 10 years of age, receiving either a low-dose or high-dose postoperative glucocorticoid treatment. Case identification and collection of a standardized dataset were retrospective, from 1 January 2010 to 31 December 2016, and prospective thereafter, until 31 December 2021. High-dose treatment included 0.5-1.0 mg subconjunctival depot dexamethasone or methylprednisolone, followed by 6-8 drops of dexamethasone for 1 week, tapered by one drop weekly. Low-dose treatment included 6 drops for 3 days, followed by 3 drops for 18 days. Sustained (>3 months) ocular hypertension or glaucoma was compared between the two groups.
Results:
Overall, 267 children (388 eyes) were included in the study. Ninety-five children (133 eyes) had received high-dose treatment and had a median follow-up time of 89 months (IQR: 57.2-107.4), while 173 children (255 eyes) had received the low-dose treatment and had a median follow-up time of 40.5 months (IQR: 22.9-60.4). Survival curves showed a lower risk of glaucoma in the low-dose group for children with axial lengths ≥18 mm.
Conclusion:
Low-dose glucocorticoid treatment was associated with a lower risk of glaucoma in children with axial lengths ≥18 mm. The same effect was not observed in children with shorter eyes. High-dose glucocorticoid should be limited in children undergoing cataract surgery.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Angle Closure Glaucoma: Treatment

